Clinical Trial Update: Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enteral glutamine for reducing intestinal permeability in critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Enteral Glutamine (glutamine)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Critical Illness, Enteral Nutrition | Phase 3 | Status: COMPLETED